Growth Differentiation Factor 15 as a Body-Brain Stress Signal in Major Depression and Insulin Resistance

OBJECTIVE: Major depressive disorder (MDD) is linked to insulin resistance, which is associated with increased risk, chronicity, and poor treatment response in depression. Growth differentiation factor 15 (GDF15), a stress-induced cytokine linking peripheral to central energy metabolism, may mediate this link, but its role in MDD is unclear. The authors assessed associations of MDD and insulin resistance with GDF15; links between GDF15, symptoms, and stress; and whether baseline GDF15 levels predict symptom persistence. METHODS: In this preregistered secondary analysis, 190 participants with MDD and 183 control participants provided blood, underwent interviews, and completed questionnaires. GDF15 values were log-transformed and analyzed with linear models. The association between GDF15 and depression severity was validated in an independent cohort of medication-free MDD patients (N=168). RESULTS: Both MDD diagnosis and insulin resistance were significantly associated with elevated GDF15 (adjusted for age and sex). Across all participants, elevated GDF15 was significantly associated with greater depressive severity, childhood trauma, and perceived stress. In stratified analyses, the association with depression severity and perceived stress was significant only in healthy control subjects. In MDD patients, baseline GDF15 was associated with persistence of symptoms across time. In the second independent sample of medication-free MDD patients, depression severity was significantly associated with GDF15. CONCLUSIONS: GDF15 is elevated in MDD and insulin resistance, indicating convergent stress-energy pathway activation, and in MDD higher GDF15 predicted symptom persistence. These findings position GDF15 as a mechanistic biomarker at the interface of psychiatric and metabolic health and reinforce the need for integrated care of metabolic and mental health.

Authors

Institutions

Publication Details

Journal
American Journal of Psychiatry
Published
2026-11-18
DOI
https://doi.org/10.1176/appi.ajp.20251275
Primary Topic
GDF15 and Related Biomarkers
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Growth Differentiation Factor 15 as a Body-Brain Stress Signal in Major Depression and Insulin Resistance

Carmen Schiweck, Klaus Peter Lieb, Sarah Mackert, Nils C. Gassen et al.
2 links
American Journal of Psychiatry
GDF15 and Related Biomarkers
article

Growth Differentiation Factor 15 as a Body-Brain Stress Signal in Major Depression and Insulin Resistance

Carmen Schiweck, Klaus Peter Lieb, Sarah Mackert, Nils C. Gassen, Sharmili Edwin Thanarajah, Jonathan Repple, Aicha Bouzouina, Yuri Milaneschi, Andreas Reif, Martin A. Picard, Silke Matura, Mareike Aichholzer, Christine Reif-Leonhard, Harry Pantazopoulos, Carmen Uckermark, Jan Engelmann, A. Balliet, J. Freiling, Miriam Grossmann, Lara Bruder, Viet Hoang Nguyen, Florian Erhardt
article en

Abstract

OBJECTIVE: Major depressive disorder (MDD) is linked to insulin resistance, which is associated with increased risk, chronicity, and poor treatment response in depression. Growth differentiation factor 15 (GDF15), a stress-induced cytokine linking peripheral to central energy metabolism, may mediate this link, but its role in MDD is unclear. The authors assessed associations of MDD and insulin resistance with GDF15; links between GDF15, symptoms, and stress; and whether baseline GDF15 levels predict symptom persistence. METHODS: In this preregistered secondary analysis, 190 participants with MDD and 183 control participants provided blood, underwent interviews, and completed questionnaires. GDF15 values were log-transformed and analyzed with linear models. The association between GDF15 and depression severity was validated in an independent cohort of medication-free MDD patients (N=168). RESULTS: Both MDD diagnosis and insulin resistance were significantly associated with elevated GDF15 (adjusted for age and sex). Across all participants, elevated GDF15 was significantly associated with greater depressive severity, childhood trauma, and perceived stress. In stratified analyses, the association with depression severity and perceived stress was significant only in healthy control subjects. In MDD patients, baseline GDF15 was associated with persistence of symptoms across time. In the second independent sample of medication-free MDD patients, depression severity was significantly associated with GDF15. CONCLUSIONS: GDF15 is elevated in MDD and insulin resistance, indicating convergent stress-energy pathway activation, and in MDD higher GDF15 predicted symptom persistence. These findings position GDF15 as a mechanistic biomarker at the interface of psychiatric and metabolic health and reinforce the need for integrated care of metabolic and mental health.

American Journal of Psychiatry
Goethe University Frankfurt (DE), University of Bonn (DE), University of Münster (DE), University Hospital Bonn (DE), Columbia University Irving Medical Center (US), University of Mississippi Medical Center (US), Imaging, Brain, and Neuropsychiatry (FR), University Medical Center of the Johannes Gutenberg University Mainz (DE), Fraunhofer Institute for Translational Medicine and Pharmacology (DE), Amsterdam Neuroscience (NL), Amsterdam Public Health (NL), University Hospital Frankfurt (DE), Public Health Service of Amsterdam (NL), Amsterdam University Medical Centers (NL), New York State Psychiatric Institute (US), Columbia University (US), Vrije Universiteit Amsterdam (NL), Amsterdam UMC Location Vrije Universiteit Amsterdam (NL)
Good health and well-being
GDF15 and Related Biomarkers
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon